Martin Edwards - Net Worth and Insider Trading
Martin Edwards Net Worth
The estimated net worth of Martin Edwards is at least $2 Million dollars as of 2024-05-31. Martin Edwards is the Director of Verona Pharma PLC and owns about 144,800 shares of Verona Pharma PLC (VRNA) stock worth over $2 Million. Martin Edwards is also the Director of Morphic Holding Inc and owns about 2,376 shares of Morphic Holding Inc (MORF) stock worth over $72,159. Details can be seen in Martin Edwards's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Martin Edwards has not made any transactions after 2023-11-20 and currently still holds the listed stock(s).
Transaction Summary of Martin Edwards
Martin Edwards Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Martin Edwards owns 6 companies in total, including KalVista Pharmaceuticals Inc (KALV) , Reata Pharmaceuticals Inc (RETA) , and Inozyme Pharma Inc (INZY) among others .
Click here to see the complete history of Martin Edwards’s form 4 insider trades.
Insider Ownership Summary of Martin Edwards
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KALV | KalVista Pharmaceuticals Inc | 2020-10-01 | director |
| RETA | Reata Pharmaceuticals Inc | 2023-09-26 | director |
| INZY | Inozyme Pharma Inc | 2020-07-23 | director |
 | | 2015-05-05 | director |
| | 2023-11-20 | director |
| | 2023-11-13 | director |
Martin Edwards Latest Holdings Summary
Martin Edwards currently owns a total of 2 stocks. Among these stocks, Martin Edwards owns 144,800 shares of Verona Pharma PLC (VRNA) as of November 20, 2023, with a value of $2 Million and a weighting of 96.04%. Martin Edwards also owns 2,376 shares of Morphic Holding Inc (MORF) as of November 13, 2023, with a value of $72,159 and a weighting of 3.96%.
Latest Holdings of Martin Edwards
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VRNA | Verona Pharma PLC | 2023-11-20 | 144,800 | 12.09 | 1,750,632 |
| MORF | Morphic Holding Inc | 2023-11-13 | 2,376 | 30.37 | 72,159 |
Holding Weightings of Martin Edwards
Martin Edwards Form 4 Trading Tracker
According to the SEC Form 4 filings, Martin Edwards has made a total of 3 transactions in Verona Pharma PLC (VRNA) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in Verona Pharma PLC is the acquisition of 33,736 shares on November 20, 2023, which cost Martin Edwards around $62,074.
According to the SEC Form 4 filings, Martin Edwards has made a total of 1 transactions in Morphic Holding Inc (MORF) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Morphic Holding Inc is the acquisition of 2,376 shares on November 13, 2023, which cost Martin Edwards around $48,803.
Insider Trading History of Martin Edwards
- 1
Martin Edwards Trading Performance
GuruFocus tracks the stock performance after each of Martin Edwards's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Martin Edwards is 46.7%. GuruFocus also compares Martin Edwards's trading performance to market benchmark return within the same time period. The performance of stocks bought by Martin Edwards within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Martin Edwards's insider trading performs compared to the benchmark.
Performance of Martin Edwards
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 26.53 | | | | | |
| Relative Return to S&P 500(%) | 21.52 | | | | | |
Martin Edwards Ownership Network
Martin Edwards Owned Company Details
What does KalVista Pharmaceuticals Inc do?
Who are the key executives at KalVista Pharmaceuticals Inc?
Martin Edwards is the director of KalVista Pharmaceuticals Inc. Other key executives at KalVista Pharmaceuticals Inc include Chief Scientific Officer Edward P. Feener , Chief Medical Officer Paul K. Audhya , and CFO and Secretary Benjamin L Palleiko .
KalVista Pharmaceuticals Inc (KALV) Insider Trades Summary
Over the past 18 months, Martin Edwards made no insider transaction in KalVista Pharmaceuticals Inc (KALV). Other recent insider transactions involving KalVista Pharmaceuticals Inc (KALV) include a net purchase of 1,251,017 shares made by Venrock Healthcare Capital Partners Iii, L.p. , a net sale of 118,495 shares made by Edward P. Feener , and a net sale of 165,254 shares made by Thomas Andrew Crockett .
In summary, during the past 3 months, insiders sold 54,832 shares of KalVista Pharmaceuticals Inc (KALV) in total and bought 0 shares, with a net sale of 54,832 shares. During the past 18 months, 555,233 shares of KalVista Pharmaceuticals Inc (KALV) were sold and 1,251,017 shares were bought by its insiders, resulting in a net purchase of 695,784 shares.
KalVista Pharmaceuticals Inc (KALV)'s detailed insider trading history can be found in Insider Trading Tracker table.
KalVista Pharmaceuticals Inc Insider Transactions
Martin Edwards Mailing Address
Above is the net worth, insider trading, and ownership report for Martin Edwards. You might contact Martin Edwards via mailing address: 15 New England Executive Park, Burlington Ma 01803.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
